153 related articles for article (PubMed ID: 15072844)
1. LIV-3D-QSAR models for PGI2 receptor ligands using multiple conformations.
Azevedo Martins RC; Girão Albuquerque M; Bicca de Alencastro R
Eur J Med Chem; 2004 Apr; 39(4):359-67. PubMed ID: 15072844
[TBL] [Abstract][Full Text] [Related]
2. Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands.
Verli H; Albuquerque MG; Bicca de Alencastro R; Barreiro EJ
Eur J Med Chem; 2002 Mar; 37(3):219-29. PubMed ID: 11900866
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
[TBL] [Abstract][Full Text] [Related]
5. New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling.
Audouze K; Nielsen EØ; Olsen GM; Ahring P; Jørgensen TD; Peters D; Liljefors T; Balle T
J Med Chem; 2006 Jun; 49(11):3159-71. PubMed ID: 16722635
[TBL] [Abstract][Full Text] [Related]
6. A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors.
Sperandio da Silva GM; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem; 2004 Jun; 12(12):3159-66. PubMed ID: 15158784
[TBL] [Abstract][Full Text] [Related]
7. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
[TBL] [Abstract][Full Text] [Related]
8. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
Peng T; Pei J; Zhou J
J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
11. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
12. Improved 3D-QSAR CoMFA of the dopamine transporter blockers with multiple conformations using the genetic algorithm.
Yuan H; Petukhov PA
Bioorg Med Chem Lett; 2006 Dec; 16(24):6267-72. PubMed ID: 17027270
[TBL] [Abstract][Full Text] [Related]
13. CoMSIA study on substituted aryl alkanoic acid analogs as GPR40 agonists.
Bhatt A; Patel PD; Patel MR; Singh S; Lau-Cam CA; Talele TT
Chem Biol Drug Des; 2011 May; 77(5):361-72. PubMed ID: 21352503
[TBL] [Abstract][Full Text] [Related]
14. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
[TBL] [Abstract][Full Text] [Related]
15. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
Lee JH; Kang NS; Yoo SE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
[TBL] [Abstract][Full Text] [Related]
16. Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key study.
Bacilieri M; Varano F; Deflorian F; Marini M; Catarzi D; Colotta V; Filacchioni G; Galli A; Costagli C; Kaseda C; Moro S
J Chem Inf Model; 2007; 47(5):1913-22. PubMed ID: 17722877
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
[TBL] [Abstract][Full Text] [Related]
18. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
San Juan AA
Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
[TBL] [Abstract][Full Text] [Related]
20. QSAR modeling using chirality descriptors derived from molecular topology.
Golbraikh A; Tropsha A
J Chem Inf Comput Sci; 2003; 43(1):144-54. PubMed ID: 12546547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
